Key Financial Inc’s Coya Therapeutics COYA Stock Holding History

Key Financial Inc’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$11.5K	–	1467
2025 Q2	$11.5K	Buy	+2,000	New	+$11.6K	﹤0.01%	818

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Key Financial Inc's COYA Position: Q3 2025 in Review

Key Financial Inc sold out of Coya Therapeutics (COYA) in Q3 2025, closing a stake of 2,000 shares — an estimated $11.5K sold.

Key Financial Inc first reported a position in COYA in Q2 2025 and held it in 1 quarter. The position peaked at $11.5K in Q2 2025. 36 funds tracked by Wall St. Rank hold COYA as of Q3 2025.

Key Financial Inc reported no remaining Coya Therapeutics position as of Q3 2025 after selling out during the quarter.
Key Financial Inc sold 2,000 Coya Therapeutics shares in Q3 2025, an estimated $11.5K.
Key Financial Inc first reported a position in Coya Therapeutics in Q2 2025 and held it in 1 quarter.
Key Financial Inc's Coya Therapeutics position peaked at $11.5K in Q2 2025.
36 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2025.

Based on Key Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.